Meeting the challenge of recurrent Clostridium difficile infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22407994.
- Also identified by DOI 10.1002/jhm.1914.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recurrent Clostridium difficile infection (CDI) is a growing problem that poses significant management challenges. There is no strong evidence to support a particular treatment strategy for recurrent CDI, especially those with multiple recurrences. However, a key strategy for reducing recurrent CDI is prompt diagnosis and treatment, facilitated by early recognition of patients at risk for recurrence.
Medical subject headings
- Anti-Bacterial Agents
- Enterocolitis, Pseudomembranous
- Metronidazole
- Vancomycin